Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/16/1998 | US5767336 Gene trap vectors comprising a type II transmembrane domain |
06/16/1998 | US5767267 DNA complexes with dyes designed for energy transfer as fluorescent markers |
06/16/1998 | US5767263 Base-modified enzymatic nucleic acid |
06/16/1998 | US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide |
06/16/1998 | US5767259 Oligonucleotides containing base-free linking groups with photoactivatable side chains |
06/16/1998 | US5767252 Neuronal cell growth factor, Narp |
06/16/1998 | US5767251 Polypeptides |
06/16/1998 | US5767250 Complexes comprising truncated CMV gH polypeptides and escort proteins |
06/16/1998 | US5767248 Alzheimers |
06/16/1998 | US5767247 Anti-annexin-V monoclonal antibodies, and preparation and use thereof |
06/16/1998 | US5767244 Protein-TRAF6 |
06/16/1998 | US5767243 A complex of human afamin and apolipoprotein a1; a monoclonal antibody specific for human afamin |
06/16/1998 | US5767242 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
06/16/1998 | US5767241 Soluble form of GMP-140 |
06/16/1998 | US5767233 Soluble cleavable substrates of the hepatitis C virus protease |
06/16/1998 | US5767102 Antisense composition and method for treatment of CMV infection |
06/16/1998 | US5767099 Containing lipophilic groups derived from steroids |
06/16/1998 | US5767075 Inhibiting protein interactions |
06/16/1998 | US5767074 Comprises a soluble c-kit ligand protein and one or more hematopoietic factors selected from interleukins, granulocyte-macrophage-colony stimulating factor, granulocyte-colonyl stimulating factor or erythropoietin |
06/16/1998 | US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same |
06/16/1998 | US5767065 Use of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4 |
06/16/1998 | US5767064 Soluble type II interleukin-1 receptors and methods |
06/16/1998 | US5767063 Human IL-8 receptor and antibodies thereto |
06/16/1998 | US5766948 Culturing neuroblast cells in vessel in serum-free basal medium supplemented with basic fibroblast growth factor, wherein surface of vessel allows attachment of cells |
06/16/1998 | US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases |
06/16/1998 | US5766946 Monoclonal antibodies to glycoprotein P |
06/16/1998 | US5766945 10A1 Retroviral packaging cells and uses thereof |
06/16/1998 | US5766943 DNA sequences for soluble form of CD23 |
06/16/1998 | US5766942 Endoribonuclease activity |
06/16/1998 | US5766941 Recombinant DNA vectors capable of expressing apoaequorin |
06/16/1998 | US5766940 Plasmid and plasmid vector |
06/16/1998 | US5766939 Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
06/16/1998 | US5766927 Stabilizing the protein by contacting the cell with a dipeptide having an n-terminal amino acid residue selected form the group consists of arginine, lysins and histidine |
06/16/1998 | US5766925 Dna fragment encoding mutant homoserine dehydrogenase originating from a corynebacterium |
06/16/1998 | US5766923 Isolated nucleic acid encoding ligands for FGFR |
06/16/1998 | US5766921 Hybrid protein C |
06/16/1998 | US5766918 Enantioselective amidases and uses thereof |
06/16/1998 | US5766917 Method for identifying and producing a protease capable of cleaving the TNF receptor |
06/16/1998 | US5766916 Fusion proteins; viricides |
06/16/1998 | US5766915 Yeast strains producing cellulolytic enzymes and methods and means for constructing them |
06/16/1998 | US5766914 Method of producing and purifying enzymes |
06/16/1998 | US5766913 Restriction enzyme digested chromosome dna fragments implanted into plasmid which can be expressed within transformed escherichia host |
06/16/1998 | US5766912 Humicola lipase produced in aspergillus |
06/16/1998 | US5766911 Mutated farnesyldiphoshate synthase capable of synthesizing geranylgeranyldiphosphate and gene coding therefor |
06/16/1998 | US5766910 Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1, 6-N-acetylglucosaminyltransfrase gene family |
06/16/1998 | US5766906 Deletion mutation in 5'nontranslated region of viral genome |
06/16/1998 | US5766905 Cytoplasmic bacteriophage display system |
06/16/1998 | US5766904 A dna fragment of phages virulent towards a streptococcus and capable of conferring resistance to at least one phage; used for making yoghurt and cheeses; sanitation |
06/16/1998 | US5766903 Circular RNA and uses thereof |
06/16/1998 | US5766902 Transfection process |
06/16/1998 | US5766901 Contacting cell with nucleic acid molecule, establishing in a sealed enclosure an incubation pressure sufficient to enhance uptake of nucleic acid molecule by the cell |
06/16/1998 | US5766900 Method of regenerating fertile transgenic Zea mays plants from protoplasts |
06/16/1998 | US5766899 Complex comprising circumsporozoite region ii-containing polypeptide, nucleic acid binding agent |
06/16/1998 | US5766892 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibiotic |
06/16/1998 | US5766891 Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase |
06/16/1998 | US5766890 Kits for suppressing inhibition of enzyme-mediated reactions by ionic detergents using high concentrations of non-ionic detergents |
06/16/1998 | US5766889 Method for determining the characteristics of the concentration growth of target nucleic acid molecules in polymerase chain reaction sample |
06/16/1998 | US5766888 Detection of carcinoma metastases by nucleic acid amplification |
06/16/1998 | US5766886 Modified antibody variable domains |
06/16/1998 | US5766885 Producing heterologous proteins in plants susceptible to a polyprotein-producing plant virus, e.g. insulin |
06/16/1998 | US5766884 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic animals |
06/16/1998 | US5766883 Fusion |
06/16/1998 | US5766882 recombinant poxviruses with foreign DNA in essential regions |
06/16/1998 | US5766881 Inoculating culture medium with recombinant bacteria expressing glutarylamidase gene from vector, incubating, recovering product |
06/16/1998 | US5766880 Lung cancer |
06/16/1998 | US5766878 Polynucleotides encoding a transcriptional response regulator of streptococcus pneumoniae |
06/16/1998 | US5766877 Genes encoding art, an agouti-related transcript |
06/16/1998 | US5766874 Kit containing d-arabinitol dehydrogenase and NAD+ for determining d-arabinitol |
06/16/1998 | US5766863 Kinase receptor activation assay |
06/16/1998 | US5766853 Method for identification of high affinity nucleic acid ligands to selectins |
06/16/1998 | US5766852 Process for lysing mycobacteria |
06/16/1998 | US5766850 Human β2 integrin α subunit |
06/16/1998 | US5766849 Methods of amplifying nucleic acids using promoter-containing primer sequence |
06/16/1998 | US5766848 Methods for identifying compounds which specifically bind a human betaine/GABA transporter |
06/16/1998 | US5766845 Immunoreactive polypeptide compositions |
06/16/1998 | US5766842 Drug resistance |
06/16/1998 | US5766609 Administering to the animal to reduce protease activity of fleas feeding on said animal; antifertility agents; veterinary medicine |
06/16/1998 | US5766608 DNA molecules which encode the fimbrin protein of Haemophilus influenzae |
06/16/1998 | US5766606 Genetic manipulation of gene encoding a group b streptococcus surface protein so that it is no longer able to bind to human iga |
06/16/1998 | US5766602 Recombinant packaging defective Sindbis virus vaccines |
06/16/1998 | US5766599 Attenuated virus; genetic engineering |
06/16/1998 | US5766598 Immunology response to lentivirus gene |
06/16/1998 | US5766594 Dna sequences encoding a polypeptide reactive with nti-mycoplasma gallisepticum chicken sera; expressed by a genetically engineered cell |
06/16/1998 | US5766591 Methods and compositions useful for inhibition of angiogenesis |
06/16/1998 | US5766588 Tumor immunotherapy using anti-idiotypic antibodies |
06/16/1998 | US5766586 Gram-positive bacteria replicon |
06/16/1998 | US5766585 Infecting bone marrow cells with recombinant retroviral expression vector that contains a polynucleotide sequence coding a biologically active interleukin receptor antagonist protein, injecting into host; antiinflammatory agents |
06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
06/16/1998 | US5766570 Lymphocyte activation antigens and antibodies thereto |
06/16/1998 | US5765538 Pump device for a fuel vapor retention system of an internal combustion engine |
06/16/1998 | CA1339912C Transformed yeasts producing lysozyme, plasmids used for this transformation, and uses thereof |
06/12/1998 | CA2192754A1 Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor |
06/11/1998 | WO1998025144A1 Methods and cell lines for identification of regulators of integrin activation and compositions identified thereby |
06/11/1998 | WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them |
06/11/1998 | WO1998024937A2 Male infertility y-deletion detection battery |
06/11/1998 | WO1998024932A1 Methods for diagnosing glaucoma and discovering anti-glaucoma drugs |
06/11/1998 | WO1998024931A1 Method for the identification of peptides that recognize specific dna sequences |
06/11/1998 | WO1998024930A1 Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate |
06/11/1998 | WO1998024928A2 Detection of chromosomal abnormalities |
06/11/1998 | WO1998024927A1 Compositions and methods for administering pneumococcal dna |